AUS
NZ
UK
CA
USA
IND
Health
Is Zoetis (NYSE:ZTS) Maintaining Its Market Position in the Animal Health Sector?
March 10, 2025 09:55 AM PDT| By Team Kalkine MediaHeadlines,Zoetis continues to expand its presence in the animal health sector with product innovations.,Recent market movements reflect adjustments in stock evaluations from various firms.,The company remains engaged in strategic initiatives to stren...
How Is Tarsus Pharmaceuticals (NASDAQ:TARS) Managing Its Product Development Strategy?
March 10, 2025 09:55 AM PDT| By Team Kalkine MediaHighlights,Institutional firms have increased their positions in Tarsus Pharmaceuticals, contributing to shifts in market participation.,The company continues to show revenue growth and structured financial management.,Tarsus Pharmaceuticals remains...
How Has UroGen Pharma (NASDAQ:URGN) Maintained Its Market Position?
March 10, 2025 09:36 AM PDT| By Team Kalkine MediaHighlights,Institutional firms have expanded their holdings in UroGen Pharma, with new positions being established.,Company executives adjusted their stock ownership, leading to shifts in internal holdings.,Financial metrics indicate stability, with...
How Is Walgreens Boots Alliance (NASDAQ:WBA) Gaining Institutional Attention?
March 10, 2025 09:32 AM PDT| By Team Kalkine MediaHighlights,Oppenheimer & Co. Inc. increased its holdings in Walgreens Boots Alliance, highlighting a shift in investment strategies.,Various institutional firms have adjusted their positions, demonstrating changes in market engagement.,Recent financi...
Is Nuvectis Pharma (NASDAQ:NVCT) Gaining More Institutional Confidence?
March 10, 2025 09:30 AM PDT| By Team Kalkine MediaHighlights,Institutional investors increase their holdings in Nuvectis Pharma.,The company advances oncology research with its lead candidate, NXP800.,Market activity reflects ongoing interest in biopharmaceutical innovation.,Institutional Investment...
Is Institutional Interest in Intellia Therapeutics (NASDAQ:NTLA) on the Rise?
March 10, 2025 08:45 AM PDT| By Team Kalkine MediaHighlights,Institutional interest grows as firms like Oppenheimer & Co. Inc. and Atria Investments expand their holdings in Intellia Therapeutics.,Company executives adjust stock positions, with recent sales activity reflecting corporate strategies.,...
Is ADMA Biologics (NASDAQ:ADMA) Becoming a Key Institutional Investment?
March 10, 2025 08:41 AM PDT| By Team Kalkine MediaHighlights,Mutual of America Capital Management LLC expanded its stake in ADMA Biologics by a slight margin during the fourth quarter.,State Street Corp and Geode Capital Management LLC significantly increased their positions in the company.,ADMA Bio...
How Is Inspire Medical Systems (NYSE:INSP) Expanding Its Market Presence?
March 10, 2025 08:15 AM PDT| By Team Kalkine MediaHighlights,Institutional holdings increase, with Smartleaf Asset Management expanding its position in Inspire Medical Systems.,Investment firms adjust stakes, reflecting broad interest in the company's financial and market performance.,Stock activity...
How Is Universal Health Services (NYSE:UHS) Strengthening Its Position in Healthcare Services?
March 10, 2025 08:06 AM PDT| By Team Kalkine MediaHighlights,Multiple institutional investors, including Smartleaf Asset Management LLC and Fisher Asset Management LLC, increased their positions in Universal Health Services.,Financial firms have made adjustments in their holdings, reflecting changes...
Is Walgreens Boots Alliance Navigating Shifts in Healthcare Retail?
March 10, 2025 01:18 AM PDT| By Team Kalkine MediaHighlights:,Mutual of America Capital Management LLC reduced its stake in Walgreens Boots Alliance (NASDAQ:WBA) during the fourth quarter, reflecting broader shifts among hedge funds and institutional investors.,Evaluation reports display mixed persp...
Is Contineum Therapeutics Shaping Biopharma Innovation?
March 10, 2025 12:28 AM PDT| By Team Kalkine MediaHighlights,Financial institutions have expressed a favorable stance on the company’s performance.,Institutional investment has risen notably during recent trading sessions.,The clinical‐stage entity is advancing its program with the drug candidate PI...
Can Institutional Shifts Redefine Pharma Performance?
March 10, 2025 12:28 AM PDT| By Team Kalkine MediaHighlights,Oppenheimer & Co. Inc. reduced its stake in Teva Pharmaceutical Industries (NYSE:TEVA) during the fourth quarter.,Institutional investors showed varied actions, with FMR LLC and Janus Henderson Group PLC increasing their holdings substanti...
Is CytomX Pioneering a New Era in Cancer Treatment?
March 10, 2025 12:28 AM PDT| By Team Kalkine MediaHighlights:,Company recorded a profit per share when a loss was previously expected.,Quarterly revenue exceeded forecasted figures by a wide margin.,Institutional investor involvement remains robust.,CytomX Therapeutics (NASDAQ:CTMX) operates in the...
Is Clarivate Plc Steering Strategic Shifts in a Dynamic Sector?
March 10, 2025 12:28 AM PDT| By Team Kalkine MediaHighlights,Institutional investment adjustments observed from prominent financial institutions.,A substantial stock repurchase program has been approved by the board.,Diverse operations span multiple global regions and sectors.,Clarivate Plc (NYSE:CL...
Medtronic’s SMART Trial Shows Evolut TAVR Outperforms SAPIEN in Key Long-Term Outcomes
March 10, 2025 12:10 AM PDT| By Team Kalkine MediaHighlights,Evolut TAVR demonstrated significantly lower rates of bioprosthetic valve dysfunction (BVD) compared to SAPIEN at two years.,Patients treated with Evolut TAVR experienced 5 times less prosthetic valve thrombosis and 9 times less structural...
Scotiabank Initiates Research Coverage on Innoviva (NASDAQ: INVA)
March 09, 2025 11:28 PM PDT| By Team Kalkine MediaHighlight,Scotiabank assigns a sector outperform rating to Innoviva; market target set at $55.00.,Innoviva posts quarterly earnings of $0.57 per share with net margin improvement.,Significant insider trading activity noted, with Alexander J. Denner r...
Morgan Stanley Reaffirms Overweight Rating for Disc Medicine (IRON)
March 09, 2025 11:28 PM PDT| By Team Kalkine MediaHighlights,Analysts maintain strong interest with multiple buy ratings and a consensus price target of $89.10 for Disc Medicine (NASDAQ:IRON).,Insider trading reveals strategic selling and reshaping of stakes, while institutional investors significan...
Is Mind Medicine Shifting Its Valuation Approach in the Biopharmaceutical Arena?
March 09, 2025 11:28 PM PDT| By Team Kalkine MediaHighlights,Robert W. Baird revised valuation from twenty-seven dollars to sixteen dollars while maintaining a positive evaluation.,A consensus valuation averaging approximately twenty-five dollars emerged from several institutional estimates.,Recent...
Could Abeona Therapeutics Reshape Gene Therapy Innovation?
March 09, 2025 11:26 PM PDT| By Team Kalkine MediaHighlight:,Abeona Therapeutics Inc (NASDAQ:ABEO) is set to release its quarterly earnings ahead of market open.,The company is focused on developing gene therapy solutions for rare and severe genetic conditions.,Market observations reveal mixed persp...
Could Jazz Pharmaceuticals Be Redefining Specialty Pharma?
March 09, 2025 11:23 PM PDT| By Team Kalkine MediaHighlights,Several financial institutions have revised their outlook for the firm.,The firm’s diversified pharmaceutical portfolio addresses a range of global medical needs.,Robust institutional participation underscores widespread market engagement....
